Quick Takeaways
- This page summarizes Aby J. Mathew's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 08 Jan 2026, 17:04.
Aby J. Mathew - 06 Jan 2026 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Signature
- /s/ Aby J. Mathew
- Issuer symbol
- BLFS
- Transactions as of
- 06 Jan 2026
- Net transactions value
- -$10,364
- Form type
- 4
- Filing time
- 08 Jan 2026, 17:04:07 UTC
- Previous filing
- 17 Dec 2025
- Next filing
- 26 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Aby J. Mathew filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 08 Jan 2026."
What Changed
- Previous filing in this sequence was filed on 17 Dec 2025.
- Current net transaction value: -$10,364.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Mathew Aby J. | EVP & Chief Scientific Officer | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL | /s/ Aby J. Mathew | 08 Jan 2026 | 0001556355 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLFS | Common Stock | Sale | $10,364 | -405 | -0.12% | $25.59 | 349,350 | 06 Jan 2026 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. |